Cargando…

Heparin-coated vs. Non-coated Cardiopulmonary Bypass Circuits: Comparing Immediate Results with Different Target Activated Clotting Time

OBJECTIVE: To compare immediate postoperative results in patients receiving heparin-albumin-coated and non-coated circuits. METHODS: A total of 241 patients undergoing on-pump cardiac surgery were divided into two groups: those receiving heparin-coated circuits (Bioline®, Maquet Cardiopulmonary AG.,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hanedan, Muhammet Onur, Yürük, Mehmet Ali, Arslan, Ali Kemal, Kılıç, Aşkın, Sayar, Ufuk, Mataracı, İlker
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cirurgia Cardiovascular 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7731843/ https://www.ncbi.nlm.nih.gov/pubmed/33306317 http://dx.doi.org/10.21470/1678-9741-2019-0387

Ejemplares similares

Early Outcomes of Sutureless Aortic Valves
por: Hanedan, Muhammet Onur, et al.
Publicado: (2016)

Inr tracking with face-to-face and phone app
por: Hanedan, Muhammet Onur, et al.
Publicado: (2023)

Low-molecular-weight heparin-coated cardiopulmonary bypass: coagulatory and clinical findings
por: Mirow, N, et al.
Publicado: (2001)

Forearm Compartment Syndrome Caused by Reperfusion Injury
por: Sayar, Ufuk, et al.
Publicado: (2014)

Investigation of the Relationship between Cerebral Near-Infrared Spectroscopy Measurements and Cerebrovascular Event in Coronary Artery Bypass Grafting Operation in Patients without Carotid Stenosis and Patients with Carotid Stenosis below Surgical Margins
por: Coskun, Ceyhun, et al.
Publicado: (2020)

Formation of intracardiac thrombus during cardiopulmonary bypass despite full heparinization and adequate activated clotting time -A case report-
por: Kim, So Yeon, et al.
Publicado: (2012)

A Blinded Randomized Trial Comparing Standard Activated Clotting Time Heparin Management to High Target Active Clotting Time and Individualized Hepcon HMS Heparin Management in Cardiopulmonary Bypass Cardiac Surgical Patients
por: Nuttall, Gregory A., et al.
Publicado: (2021)

Electrochemical Polymerization of PEDOT–Graphene Oxide–Heparin Composite Coating for Anti-Fouling and Anti-Clotting of Cardiovascular Stents
por: Yang, Ming-Chien, et al.
Publicado: (2019)

Lepirudin as an alternative to "heparin allergy" during cardiopulmonary bypass
por: Parissis, Haralabos
Publicado: (2011)

Bivalirudin for cardiopulmonary bypass in a patient with heparin allergy
por: Boysan, Emre, et al.
Publicado: (2023)

Humoral immune response and coated or uncoated oxygenators during cardiopulmonary bypass surgery
por: Karakisi, Sedat Ozan, et al.
Publicado: (2016)

Heparin Resistance During Cardiopulmonary Bypass in Adult Cardiac Surgery
por: Chen, Yufan, et al.
Publicado: (2022)

Cardiopulmonary Bypass Surgery in a Patient with Unexpected Heparin-Induced Thrombocytopenia
por: Miyagawa, Atsushi, et al.
Publicado: (2022)

How to Solve the Conundrum of Heparin-Induced Thrombocytopenia during Cardiopulmonary Bypass
por: Revelly, Etienne, et al.
Publicado: (2023)

Cardiopulmonary bypass using heparin surface treatment: influence on memory and neurological deviations
por: Svenmarker, S, et al.
Publicado: (2000)

Pharmacokinetic model of unfractionated heparin during and after cardiopulmonary bypass in cardiac surgery
por: Jia, Zaishen, et al.
Publicado: (2015)

Abrupt formation of intracardiac thrombus during cardiopulmonary bypass with full heparinization -A case report-
por: Kim, Seong-Hyop, et al.
Publicado: (2012)

Risk Factors Associated with Difficult Reversal of Heparin by Protamine Sulfate in Cardiopulmonary Bypass: An Ignored Issue
por: Ku, Min Jung, et al.
Publicado: (2020)

Phosphorylcholine-coated cardiopulmonary bypass in paediatric cardiac surgery improves biocompatibility: reduced contact activation and endothelin-1 release
por: Harig, F, et al.
Publicado: (2001)

Heparin-Coated Dendronized Hyperbranched Polymers for Antimalarial Targeted Delivery
por: San Anselmo, María, et al.
Publicado: (2022)

Cardiopulmonary Bypass
por: Rondelez, Luc, et al.
Publicado: (2010)

Is the precise control of circulating heparin levels during cardiopulmonary bypass beneficial in paediatric open-heart surgery?
por: Codispoti, M, et al.
Publicado: (1999)

Anticoagulation Management and Heparin Resistance During Cardiopulmonary Bypass: A Survey of Society of Cardiovascular Anesthesiologists Members
por: Sniecinski, Roman M., et al.
Publicado: (2019)

An Antithrombin-Heparin Complex Increases the Anticoagulant Activity of Fibrin Clots
por: Smith, Lesley J., et al.
Publicado: (2008)

Subfatin, Asprosin, Alamandine and Maresin-1 Inflammation Molecules in Cardiopulmonary Bypass
por: Hanbeyoglu, Onur, et al.
Publicado: (2023)

Rotational thromboelastometry for diagnosing sudden hyperfibrinolysis immediately after cardiopulmonary bypass during cardiac surgery
por: Kim, Joung-Min, et al.
Publicado: (2013)

Therapeutic potential of fibrinogen γ-chain peptide-coated, ADP-encapsulated liposomes as a haemostatic adjuvant for post-cardiopulmonary bypass coagulopathy
por: Ishida, Osamu, et al.
Publicado: (2020)

Postoperative Breath-Holding Spells Requiring Cardiopulmonary Resuscitation After Cardiopulmonary Bypass
por: Kreis, Rebecca, et al.
Publicado: (2022)

Slippery liquid infused fluoropolymer coating for central lines to reduce catheter associated clotting and infections
por: Bandyopadhyay, Saibal, et al.
Publicado: (2020)

EFFECT OF HEPARIN AND BIVALIRUDIN ON THE KINETICS OF CLOT FORMATION: VISCOELASTIC COAGULATION TESTING
por: Hasija, Suruchi, et al.
Publicado: (2017)

Antifungal and Cytotoxic Evaluation of Photochemically Synthesized Heparin-Coated Gold and Silver Nanoparticles
por: Rodriguez-Torres, María del Pilar, et al.
Publicado: (2020)

Can Heparin-Coated ECMO Cannulas Induce Thrombocytopenia in COVID-19 Patients?
por: Steinlechner, Barbara, et al.
Publicado: (2021)

Basics of cardiopulmonary bypass
por: Sarkar, Manjula, et al.
Publicado: (2017)

Revascularization Strategy with prolonged cardiopulmonary bypass in a patient with multiple morbidity factors and serious left main coronary artery lesion
por: Yetkin, Ufuk, et al.
Publicado: (2015)

Protamine dose to neutralize heparin at the completion of cardiopulmonary bypass can be reduced significantly without affecting post-operative bleeding
por: Lee, Min-Ho, et al.
Publicado: (2023)

Study protocol of a pilot study on sirolimus-coated balloon angioplasty in salvaging clotted arteriovenous graft
por: Tan, Ru Yu, et al.
Publicado: (2020)

Effects of cardiopulmonary bypass on new-onset atrial fibrillation
por: Gökalp, Orhan, et al.
Publicado: (2016)

Cardiopulmonary Bypass, Inflammation and How to Defy it: Focus on Pharmacological Interventions
por: Dabbagh, Ali, et al.
Publicado: (2012)

Physical Properties of Electropolished CoCrMo Alloy Coated with Biodegradable Polymeric Coatings Releasing Heparin after Prolonged Exposure to Artificial Urine
por: Kajzer, Wojciech, et al.
Publicado: (2021)

Comparison of activated clotting times measured using the Hemochron Jr. Signature and Medtronic ACT Plus during cardiopulmonary bypass with acute normovolemic haemodilution
por: Lee, Jung Min, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_215i22p025s9jsgkdlojjn4kd4